PREPARATION AND EVALUATION OF NANOSPONGES BASED TRAMADOL HCL C/R TABLETS USING DESIGN OF EXPERIMENT
DOI:
https://doi.org/10.22159/ijap.2022v14i3.44278Keywords:
Tramadol, Opioid analgesic, Nanosponges, Tablets, Experimental designAbstract
Objective: The goal was to develop a controlled release formulation of tramadol utilizing the cyclodextrin-based nanosponges as a nanocarrier.
Methods: Based on the preliminary trials a 3-factor, 3-level Box-Behnken design was employed. Five types of nanosponges from β-cyclodextrin (NS1-NS5) were purposely designed. Tramadol was loaded into nanosponges by the freeze-drying method. The prepared nanosponges were characterized and formulated into tablets and evaluated.
Results: The particle sizes of tramadol-loaded nanosponges are in between 34.38 to 134.26 nm, encapsulation efficiency of 41.13-86.72% and drug release% at 6h of 52.34-81.12%. In vitro release studies showed that more than 90 % of the drug were released from nanosponge formulations as compared to only around 20% from free drug suspension after 24 h. The FTIR, DSC and XRPD studies confirmed the interaction of Tramadol with nanosponges. TEM image revealed the spherical structure of drug-loaded nanosponges. The drug-loaded in the nanosponge structure can be retained and released slowly over time. The nanosponges were formulated into tablets and evaluated for weight variation, hardness, friability and disintegration studies and obtained satisfactory results. In vitro release of drug from tablet showed controlled release behavior for a period of 12 h. The percentage of tramadol released from nanosponges tablets after was 87.48 percent and stability studies indicated no significant changes within 6 months.
Conclusion: Cyclodextrin-based nanosponges showed superior complexing ability with increased solubility of poorly soluble Tramadol tablets made for controlled drug delivery, which can reduce dosing frequency.
Downloads
References
Mongin G. Tramadol extended-release formulations in the management of pain due to osteoarthritis. Expert Rev Neurother. 2007;7(12):1775-84. doi: 10.1586/14737175.7.12.1775, PMID 18052769.
Zehr L. Cipher gets U.S. patent for tramadol; 2010.
Joshi NC, Ahmad Z, Mishra SK, Singh R. Formulation and evaluation of matrix tablet of tramadol. Indian J Pharm Educ Res. 2011 Oct 1;45(4):360-3.
Bhowmik, Himangshu, Venkatesh D, Kuila, Anuttam, Kumar, Kammari. Nanosponges: a review. Int J Appl Pharm. 2018;10:1.
Subramanian, Selvamuthukumar, Anandam, Singireddy, Kannan. Krishnamoorthy Rajappan Manavalan Nanosponges Novel Cl drug deliv syst-review. Journal of Pharmacy and Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences. 2012;15:103-11.
Pawar S, Shende P, Trotta F. Diversity of β-cyclodextrin-based nanosponges for the transformation of actives. Int J Pharm. 2019 Jun 30;565:333-50. doi: 10.1016/j.ijpharm.2019.05.015, PMID 31082468.
Kaur S, Kumar S. The nanosponges: an innovative drug delivery system. Asian J Pharm Clin Res. 2019:60-7.
Swaminathan S, Vavia PR, Trotta F, Torne S. Formulation of β-cyclodextrin based nanosponges of itraconazole. J Inclus Phenom Macrocyclic Chem. 2007 Apr;57(1):89-94.
Bindiya P, Om B, Kuldeep R, Riddhi P, Varsha A. An assessment on preparations, characterization, and poles apart appliances of nanosponge. Int J PharmTech Res. 2010;6(6):1898-907.
Singireddy A, Pedireddi SR, Subramanian S. Optimization of reaction parameters for the synthesis of cyclodextrin nanosponges in controlled nanoscopic size dimensions. J Polym Res. 2019 Apr;26(4):1-2.
Rangaraj N, Pailla SR, Chowta P, Sampathi S, Nagarjun Rangaraj, Sravanthi Reddy Pailla, Paramesh Chowta. Fabrication of ibrutinib nanosuspension by quality by design approach: intended for enhanced oral bioavailability and diminished fast-fed variability. AAPS PharmSciTech. 2019;20(8):326. doi: 10.1208/s12249-019-1524-7, PMID 31659558.
Anandam S, Selvamuthukumar S. Optimization of microwave-assisted synthesis of cyclodextrin nanosponges using response surface methodology. J Porous Mater. 2014 Dec 1;21(6):1015-23.
Shivakumar HN, Patel PB, Desai BG, Ashok P, Arulmozhi S. Design and statistical optimization of glipizide-loaded lipospheres using response surface methodology. Acta Pharm. 2007 Sep 1;57(3):269-85. doi: 10.2478/v10007-007-0022-8, PMID 17878108.
Naima, Ziane Zafour, Hadj. Formulation of β-cyclodextrin nanosponges by polycondensation method: application for natural drugs delivery and preservation. Journal of Materials, Processes and Environment. Nait Bachir, Yacine and Medjekane, Meriem and Benaoudj, F and Sahraoui. 2017;5:81-5.
Moin A, Roohi NF, Rizvi SM, Ashraf SA, Siddiqui AJ, Patel M, Ahmed SM, Gowda DV, Adnan M. Design and formulation of polymeric nanosponge tablets with enhanced solubility for combination therapy. RSC Adv. 2020;10(57):34869-84.
Gupta SK, Huneza A, Patra S. Formulation, development and in vitro evaluation of tramadol extended-release tablets. Int J Pharm Pharm Sci. 2019.
Singireddy A, Subramanian S. Cyclodextrin nanosponges to enhance the dissolution profile of quercetin by inclusion complex formation. Part Sci Technol. 2016 May 3;34(3):341-6.
Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63(3):235-59. doi: 10.1016/s0168-3659(99)00204-7, PMID 10601721.
Madhuri, Shete, Rajkumar. Formulation and evaluation of gliclazide nanosponges. Solunke, Rahul and Borge, Uday and Murthy, Krishna and Deshmukh. Int J Appl Pharm. 2019;11:181-9.
Kumar JA, Bhikshapathi DVRN, Mamatha P. Design and optimization of Ibrutinib solid lipid nanoparticles using design of experiment. Int J Biol Pharm Allied Sci 2021 Sep;10(9)Special Issue:723-37.
El-Assal M. Nano-sponge novel drug delivery system as carrier of anti-hypertensive drug. Int J Pharm Pharm Sci. 2019:47-63.
Masilungan FC, Kraus KF. Determination of precompression and compression force levels to minimize tablet friability using simplex. Drug Dev Ind Pharm. 1989;15:1771-8.
Silva L, Mario Boldo E. Optimization of albendazole 400 Mg tablet compression process using design of experiment (doe) approach. Int J Pharm Pharm Sci. 2021;10:1-6.
Published
How to Cite
Issue
Section
Copyright (c) 2022 DUGGI VAMSHIDHAR REDDY, AMBATI SAMBASHIVA RAO
This work is licensed under a Creative Commons Attribution 4.0 International License.
